Daniel Trifiletti, MD
Enriched profileProfessor of Radiation Oncology, Mayo Clinic in Jacksonville, Florida · Mayo Clinic
Daniel Trifiletti is Professor of Radiation Oncology, Mayo Clinic in Jacksonville, Florida at Mayo Clinic. OpenAlex indexes 443 publications with 9,055 citations (h-index 46); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 26 Oct 2026
Overview
Updated 27 Oct 2026
Daniel Trifiletti, MD, is Professor of Radiation Oncology, Mayo Clinic in Jacksonville, Florida. The public record shows 443 publications with 9,055 citations (h-index 46), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Advanced Radiotherapy Techniques. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 6 companies.
- Most recent indexed publication: 2026 · Neuro-oncology advances
- Top research focus: Glioma Diagnosis and Treatment
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 165.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 26 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20257 payments
- Telix PharmaceuticalsProgram year20256 payments
- Monteris Medical CorporationProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
51.7%Benzodiazepine51.7%Lorazepam100%Part D≥11 patientsDermatology
48.3%Corticosteroid48.3%Methylprednisolone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 26 Oct 2026
62 congress contributions (2014–2026) across ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Conventional Target Volume Delineation in Glioblastoma: Insights from a Large Multicenter Academic Practice
ASTRO Annual Meeting
ASTRO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Defining rapid early progression in glioblastoma-A volumetric approach.
Neuro-oncology advances
Article2026 - Trends in Long-Term Survival Among Patients With De Novo Metastatic Cancer.
JCO oncology practice
Article2026 - Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarker.
Journal of neuro-oncology
Article2025 - Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach.
Journal of neuro-oncology
Article2024 - Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: A Reason for Optimism While Avoiding Overreaching Interpretations.
Journal of clinical oncology
Letter2024
Most-cited works
by citation count (OpenAlex)- 01A population-based study of cardiovascular disease mortality risk in US cancer patientsArticle932 citations2019
- 02Epidemiology of liver metastasesArticle298 citations2020
- 03
- 04
- 05Carbon Ion Therapy: A Modern Review of an Emerging TechnologyArticle251 citations2020
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/daniel-trifiletti-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
mayo.edu/research/faculty/trifiletti-daniel-m-m-d/bio-20403525
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗ - Other
mayoclinic.org/biographies/trifiletti-daniel-m-m-d/bio-20341039
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →am25.astro.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center